Vertex Pharmaceuticals
VRTX | NASDAQ
$553.15
-$5.73 (-1.03%)
At close: Nov 2, 2026, 4:00 PM ET
$553.64
+$0.49 (+0.09%)
After-hours:
Nov 2, 2026, 4:39 PM ET
Fiscal Quarter Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | 1.1B | 1.03B | 1.19B | 1.08B | 1.03B | 646.3M | 913M | 1.05B | -3.59B | 1.1B | 968.8M | 1.04B | 915.7M | 699.8M | 818.9M | 930.5M | 810.5M | 762.1M | 770.11M | 851.93M | 66.92M | 653.14M |
Depreciation & Amortization | 56.5M | 55.9M | 55.7M | 54M | 51.7M | 48.4M | 46.5M | 53.2M | 54M | 53.5M | 59M | 42.1M | 41.4M | 38.8M | 38.4M | 36.7M | 37.3M | 35.9M | 33.83M | 31.7M | 31.24M | 28.83M |
Stock-Based Compensation | 170.2M | 166.4M | 157.6M | 194.9M | 167.3M | 166.1M | 167.8M | 184.6M | 154.2M | 191.9M | 208.6M | 130.9M | 119.3M | 122.4M | 111.5M | 135.6M | 113.9M | 130.3M | 118.61M | 103M | 104.62M | 115.17M |
Other Working Capital | 119.6M | 267M | -809.3M | 375.9M | 27M | 42M | -490.1M | 325.7M | -244.2M | 460.9M | -752.5M | 283.3M | 285.5M | 276.3M | -182.7M | 297M | 455.8M | 144.9M | 151.25M | 109.79M | -178.58M | 147.94M |
Other Non-Cash Items | -16.4M | -5M | 10.9M | -4.1M | 67.4M | 418.2M | -34.1M | 52.4M | -8M | -9.4M | -31.9M | -13.3M | -10.8M | 13.4M | 52.4M | -45.8M | 23.8M | 73M | -20.3M | -36.08M | -155K | 50.73M |
Deferred Income Tax | -69.7M | -65.3M | 30.5M | -235.9M | -113.8M | -191.6M | 51.6M | -123.3M | -118.8M | -158.3M | -131M | -115.5M | -176.6M | -113.4M | 148.1M | -182.3M | -229.4M | -12.3M | -41.95M | 68.24M | -237.94M | 57.04M |
Change in Working Capital | -115M | 244.7M | -947.8M | 149.6M | -132.4M | -268.5M | -560.2M | 157.5M | -241.4M | 129.3M | -838.9M | 188.9M | 245.4M | 138.9M | -90.9M | 80.8M | 383.7M | -32.8M | 134.68M | -91.57M | -164.46M | 16.14M |
Operating Cash Flow | 1.13B | 1.43B | 498M | 1.24B | 1.07B | 818.9M | 584.6M | 1.37B | -3.75B | 1.31B | 234.6M | 1.27B | 1.13B | 899.9M | 1.08B | 955.5M | 1.14B | 956.2M | 994.99M | 927.22M | -199.77M | 921.06M |
Capital Expenditures | -112.2M | -133.4M | -149.4M | -101.8M | -145.7M | -40.7M | -92.6M | -67.7M | -76.7M | -248.4M | -58.1M | -40.6M | -59.6M | -42.1M | -33.6M | -54.2M | -53.3M | -63.6M | -61.8M | -52.4M | -49.9M | -70.9M |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 10M | n/a | 77M | n/a | n/a | n/a |
Purchase of Investments | -2.36B | -2.51B | -1.23B | -1.35B | -2.17B | -1.65B | -2.16B | -1.13B | -1.55B | -2.6B | -988.5M | -407.2M | -549.3M | -1.84B | -322.7M | -227.7M | -120.8M | -117.1M | -119.45M | -246.29M | -118M | -121.46M |
Sales Maturities Of Investments | 2.35B | 2.21B | 1.11B | 1.33B | 1.84B | 1.64B | 1.46B | 1.11B | 1.18B | 710.5M | 218.1M | 331.2M | 334.9M | 50M | 484.1M | 193.6M | 112.6M | 129.7M | 47.17M | 230.86M | 103.2M | 118.07M |
Other Investing Acitivies | 73.8M | n/a | -15.9M | 800K | -4.3M | -5.3M | -30.9M | -266.1M | -22.7M | -180M | -58M | -1.1M | -29.9M | n/a | 47.8M | -295.9M | -10M | n/a | -77M | 15M | -15M | n/a |
Investing Cash Flow | -45.8M | -431.9M | -288.1M | -117M | -484.5M | -55.8M | -821.9M | -348M | -463.7M | -2.14B | -886.5M | -117.7M | -303.9M | -1.83B | 175.6M | -384.2M | -61.5M | -51M | -134M | -52.95M | -79.64M | -74.31M |
Debt Repayment | n/a | n/a | -1.4M | -1.4M | -1.3M | -1.3M | -1.3M | -5.4M | -13.7M | -13.2M | -12M | -11.3M | -11M | -10.6M | -10.4M | -49.5M | -12.7M | -12.9M | -2.46M | -11.1M | -2.31M | -8.6M |
Common Stock Repurchased | -469.5M | -336.9M | -130.9M | -1.07B | -391.8M | -426.1M | -417.9M | -307.7M | -320.3M | -131.2M | -149.5M | -117M | -28.3M | -132.8M | n/a | n/a | n/a | n/a | -368.18M | -632.27M | n/a | -424.95M |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -4.9M | -228.9M | 1.1M | -89.9M | -5.2M | -269.7M | -6.4M | -82.8M | -79.6M | -230M | -4.7M | -52.1M | -2M | -165.5M | -1M | -47.3M | -4M | -116.2M | -316K | -27.15M | -2.08M | -100.66M |
Financial Cash Flow | -426.7M | -538.8M | -77.2M | -1.15B | -349.2M | -680.4M | -391.3M | -387.5M | -358.6M | -357.5M | -119.8M | -165M | 17.3M | -294.7M | 40.2M | -60.2M | 47.7M | -95.4M | -336.24M | -656.66M | 33.55M | -518.65M |
Net Cash Flow | 649.2M | 417.1M | 140M | -34.2M | 296.6M | 113.2M | -675.9M | 657.1M | -4.58B | -1.2B | -744.3M | 963.2M | 857.8M | -1.22B | 1.34B | 472.9M | 1.1B | 803.9M | 519.89M | 209.15M | -241.84M | 324.06M |
Free Cash Flow | 1.01B | 1.29B | 348.6M | 1.14B | 927.4M | 778.2M | 492M | 1.3B | -3.83B | 1.06B | 176.5M | 1.23B | 1.07B | 857.8M | 1.04B | 901.3M | 1.09B | 892.6M | 933.2M | 874.8M | -249.6M | 850.1M |
Adj. Free Cash Flow | 843M | 1.13B | 191M | 944.7M | 760.1M | 612.1M | 324.2M | 1.12B | -3.98B | 866.3M | -32.1M | 1.1B | 955.5M | 735.4M | 933.3M | 765.7M | 972.6M | 762.3M | 814.59M | 771.8M | -354.22M | 734.93M |
Maintenance CapEx | -56.5M | -55.9M | -85.59M | -40.13M | -81.08M | -23.89M | -16.18M | -11.81M | -47.16M | -187.86M | -17.15M | -12.18M | -3.04M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -18.71M |
Growth CapEx | -55.7M | -77.5M | -63.81M | -61.67M | -64.62M | -16.81M | -76.42M | -55.89M | -29.54M | -60.54M | -40.95M | -28.42M | -56.56M | -42.1M | -33.6M | -54.2M | -53.3M | -63.6M | -61.8M | -52.4M | -49.9M | -52.19M |
Owner Earnings | 1.07B | 1.37B | 412.41M | 1.2B | 992.02M | 795.01M | 568.42M | 1.36B | -3.8B | 1.12B | 217.45M | 1.26B | 1.13B | 899.9M | 1.08B | 955.5M | 1.14B | 956.2M | 995M | 927.2M | -199.7M | 902.29M |
Add to Watchlist
Select watchlists to add or remove VRTX